Medicare Coverage Solidified for ReWalk Personal Exoskeleton
2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons.
Finalized Medicare reimbursement pathway for the ReWalk Personal Exoskeleton |
2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons.
Recently ReWalk Robotics™ announced the acquisition of AlterG® Inc., a global industry leader in innovative rehabilitation technology and the makers of the[...]
Combined Company Expands Patient and Clinician Access to Innovative Rehabilitation Technologies for Home and Clinic Use Transaction Projected to Increase Revenue Growth[...]
ReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum Basis[...]
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs Paralyzed individuals with spinal[...]
The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological[...]
Experts outline potential for improved stroke patient outcomes, cost-effectiveness through use of the ReStore device in the rehabilitation setting MARLBOROUGH, Mass., March 3,[...]
This supply contract is the first between ReWalk and a German company health insurance fund MARLBOROUGH, Mass. and BERLIN, March 2, 2021 /PRNewswire/ — ReWalk Robotics, Ltd. (Nasdaq:[...]
Covid-19 Pandemic Has Further Illustrated Need for Innovative Stroke Rehab Solutions MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ — ReWalk Robotics, Ltd. (Nasdaq:[...]
© 2024 Lifeward, Inc.
Our mission at Lifeward is to relentlessly drive innovation to change the lives of people with physical limitations or disabilities.
We are committed to delivering groundbreaking solutions that empower individuals to do what they love.